Representative Jonathan L. Jackson (D-Illinois) recently bought shares of Tenet Healthcare Corporation (NYSE:THC). In a filing disclosed on January 08th, the Representative disclosed that they had bought between $15,001 and $50,000 in Tenet Healthcare stock on December 10th. The trade occurred in the Representative’s “MORGAN STANLEY TRUST ACCOUNT” account.
Representative Jonathan L. Jackson also recently made the following trade(s):
- Sold $15,001 – $50,000 in shares of Robinhood Markets (NASDAQ:HOOD) on 12/22/2025.
- Purchased $15,001 – $50,000 in shares of Palantir Technologies (NASDAQ:PLTR) on 12/22/2025.
- Sold $15,001 – $50,000 in shares of MercadoLibre (NASDAQ:MELI) on 12/10/2025.
- Sold $50,001 – $100,000 in shares of Netflix (NASDAQ:NFLX) on 12/8/2025.
- Purchased $50,001 – $100,000 in shares of Shopify (NASDAQ:SHOP) on 12/8/2025.
- Sold $1,001 – $15,000 in shares of Meta Platforms (NASDAQ:META) on 11/11/2025.
- Purchased $1,001 – $15,000 in shares of State Street (NYSE:STT) on 11/11/2025.
- Sold $1,001 – $15,000 in shares of T-Mobile US (NASDAQ:TMUS) on 11/11/2025.
- Sold $15,001 – $50,000 in shares of Doximity (NASDAQ:DOCS) on 11/6/2025.
- Purchased $15,001 – $50,000 in shares of Robinhood Markets (NASDAQ:HOOD) on 11/6/2025.
Tenet Healthcare Price Performance
Tenet Healthcare stock opened at $201.46 on Friday. The company has a market capitalization of $17.71 billion, a price-to-earnings ratio of 13.81, a PEG ratio of 0.86 and a beta of 1.41. The stock’s 50 day moving average is $202.22 and its 200-day moving average is $189.81. The company has a current ratio of 1.71, a quick ratio of 1.64 and a debt-to-equity ratio of 2.27. Tenet Healthcare Corporation has a 12 month low of $109.82 and a 12 month high of $222.82.
Analysts Set New Price Targets
Several equities analysts recently commented on the stock. Wall Street Zen upgraded shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday. Weiss Ratings upgraded shares of Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, December 29th. The Goldman Sachs Group initiated coverage on shares of Tenet Healthcare in a research report on Tuesday, October 14th. They issued a “buy” rating and a $224.00 price target for the company. Guggenheim increased their price target on Tenet Healthcare from $238.00 to $257.00 and gave the stock a “buy” rating in a research report on Tuesday, December 2nd. Finally, Cantor Fitzgerald lifted their price objective on Tenet Healthcare from $190.00 to $245.00 and gave the company an “overweight” rating in a report on Wednesday, October 29th. One research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $233.81.
View Our Latest Analysis on THC
Insider Transactions at Tenet Healthcare
In related news, Director Tammy Romo sold 15,099 shares of the firm’s stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $200.81, for a total transaction of $3,032,030.19. Following the sale, the director owned 47,267 shares of the company’s stock, valued at $9,491,686.27. This trade represents a 24.21% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider R. Scott Ramsey sold 13,322 shares of the company’s stock in a transaction dated Thursday, November 6th. The stock was sold at an average price of $205.11, for a total value of $2,732,475.42. The SEC filing for this sale provides additional information. Insiders have sold a total of 45,500 shares of company stock valued at $9,247,071 over the last quarter. 0.81% of the stock is currently owned by insiders.
Hedge Funds Weigh In On Tenet Healthcare
Hedge funds and other institutional investors have recently modified their holdings of the business. Triumph Capital Management bought a new stake in shares of Tenet Healthcare during the 3rd quarter worth $25,000. William B. Walkup & Associates Inc. bought a new position in shares of Tenet Healthcare in the third quarter worth about $32,000. Westside Investment Management Inc. grew its holdings in shares of Tenet Healthcare by 100.0% during the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock valued at $39,000 after purchasing an additional 96 shares during the last quarter. Chung Wu Investment Group LLC acquired a new position in Tenet Healthcare during the 2nd quarter worth approximately $35,000. Finally, Trust Co. of Vermont acquired a new stake in Tenet Healthcare in the third quarter valued at approximately $41,000. Institutional investors own 95.44% of the company’s stock.
About Representative Jackson
Jonathan Jackson (Democratic Party) is a member of the U.S. House, representing Illinois’ 1st Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027.
Jackson (Democratic Party) is running for re-election to the U.S. House to represent Illinois’ 1st Congressional District. He declared candidacy for the 2026 election.
Jonathan Jackson was born in Chicago, Illinois. Jackson graduated from Whitney Young High School. He earned an M.B.A. from Northwestern University. Jackson’s career experience includes working as an investment analyst and an entrepreneur.
Tenet Healthcare Company Profile
Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.
In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.
Read More
- Five stocks we like better than Tenet Healthcare
- Wall Street Stockpicker Names #1 Stock of 2026
- A U.S. “birthright” claim worth trillions – activated quietly
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Market Panic: Trump Just Dropped a Bomb on Your Stocks
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
